US regulators are greenlighting a new weight-loss drug called Contrave, the third in a string of approvals for anti-obesity treatments. The drug was developed by Orexigen Therapeutics Inc, based in La Jolla, California.
You are here: / / FDA approves weight-loss drug Contrave
This site uses Akismet to reduce spam. Learn how your comment data is processed.